Grupo Medinfar

MEDINFAR is a fully integrated Portuguese Pharmaceutical Company headquartered in Lisbon. Founded in 1970, MEDINFAR is focused in R&D, Production, Distribution, Marketing & Sales. Besides its own brands it markets licensed products in partnerships with several top international pharmaceutical companies. MEDINFAR is the Nº1 Portuguese Company in Dermatology as in Consumer Health. MEDINFAR has a wide range of products from Prescription Medicines to Generics, OTC/Consumer Health products and veterinary products. In 2001, with the acquisition of the manufacturing unit, FARMALABOR, Medinfar increased its productive capacity. This unit has an area of 47.000 m2 and produced in 2013 around 15 milion packages. MEDINFAR Group: - MEDINFAR Farma – Prescription Medicines Marketing&Sales. Main therapeutic areas: Respiratory, Dermatology, Cardiology and Diabetes - GP: Genéricos Portugueses – Generic Drugs Marketing&Sales. Main therapeutic areas: Neurology, Psychiatry, Cardiovascular, Osteoporosis and Urology - MEDINFAR CONSUMER HEALTH – Promotion and commercialization of non-prescription medicines and other health products. Main therapeutic areas: Cough&Cold, GERD&Heartburn, Antiviral, Asthenia and Vitamins - FARMALABOR – Manufacturing unit - MEDINFAR SOROLÓGICO – Veterinary Unit: veterinary drugs, devices and herd vaccines. Main therapeutic areas: anesthetics, antibiotics, fluid therapy, multivitamin, iron and shampoos - Cytothera – Biotechnology Unit: First company in Europe processing and cryopreserving umbilical cord tissue stem cells As a result of its globalization challenge, Medinfar Group is present in more than 40 countries around the world, through its affiliate in Morocco and distributors throughout Europe, FWA, PALOP, Middle East, CIS and Asia. Maintaining its commitment to quality, its well-trained workforce and state of the art manufacturing facilities aim to bring products of the highest quality to worldwide markets.